Ensysce Biosciences Stock In The News

ENSC Stock  USD 0.59  0.10  20.41%   
Our overall analysis of Ensysce Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Ensysce Biosciences. The specific impact of Ensysce Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ensysce Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ensysce Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ensysce Biosciences Backtesting and Ensysce Biosciences Hype Analysis.
For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.

Ensysce Biosciences Today Top News and Investor Outlook

Yahoo News
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.59%
https://finance.yahoo.com/news/u-stocks-mixed-close-trade-213506844.html
 Neutral
Yahoo News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02%
https://finance.yahoo.com/news/u-stocks-higher-close-trade-213506207.html
 Neutral
Yahoo News
10 Stocks Targeted By Short Sellers Recently
https://finance.yahoo.com/news/10-stocks-targeted-short-sellers-195952283.html
 Bullish
Yahoo News
10 Penny Stocks with Insider Buying
https://finance.yahoo.com/news/10-penny-stocks-insider-buying-204206513.html
 Bullish
Macroaxis News: globenewswire.com
Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 25, 2023
https://www.globenewswire.com/news-release/2023/01/23/2593160/0/en/Diamond-Equity-Research-to-Host-Spotlight-Emerging-Growth-Invitational-Virtual-Investor-Conference-on-January-25-2023.html
 Bullish
Yahoo News
Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 25, 2023
https://finance.yahoo.com/news/diamond-equity-research-host-spotlight-130000536.html
 Bullish
Macroaxis News: globenewswire.com
Diamond Equity Research Initiates Coverage on Ensysce Biosciences, Inc. (NASDAQ: ENSC)
https://www.globenewswire.com/news-release/2022/12/14/2573632/0/en/Diamond-Equity-Research-Initiates-Coverage-on-Ensysce-Biosciences-Inc-NASDAQ-ENSC.html
 Neutral
Macroaxis News: globenewswire.com
Ensysce Biosciences Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
https://www.globenewswire.com/news-release/2022/03/31/2414342/0/en/Ensysce-Biosciences-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results.html
 Neutral
Macroaxis News: globenewswire.com
Ensysce Biosciences Announces Participation in the 34th Annual Roth Conference
https://www.globenewswire.com/news-release/2022/02/23/2390385/0/en/Ensysce-Biosciences-Announces-Participation-in-the-34th-Annual-Roth-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Ensysce Biosciences Appoints Industry Veteran Lee Rauch to Board of Directors
https://www.globenewswire.com/news-release/2022/02/08/2381322/0/en/Ensysce-Biosciences-Appoints-Industry-Veteran-Lee-Rauch-to-Board-of-Directors.html
 Bullish

Ensysce Biosciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ensysce and other traded companies coverage with news coverage. We help investors stay connected with Ensysce headlines for the 2nd of December to make an informed investment decision based on correlating the impacts of news items on Ensysce Stock performance. Please note that trading solely based on the Ensysce Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ensysce Biosciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ensysce Biosciences investors visualize upcoming and past events in order to time the market based on Ensysce Biosciences noise-free hype analysis.
Ensysce Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ensysce earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ensysce Biosciences that are available to investors today. That information is available publicly through Ensysce media outlets and privately through word of mouth or via Ensysce internal channels. However, regardless of the origin, that massive amount of Ensysce data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ensysce Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ensysce Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ensysce Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ensysce Biosciences alpha.

Ensysce Largest EPS Surprises

Earnings surprises can significantly impact Ensysce Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-08
2024-06-30-0.39-0.220.1743 
2023-11-09
2023-09-30-1.06-0.870.1917 
2024-05-13
2024-03-31-0.9-0.550.3538 
2024-11-07
2024-09-30-0.290.070.36124 
2024-03-15
2023-12-31-0.87-1.37-0.557 
2022-08-11
2022-06-30-3.4-4.8-1.441 
View All Earnings Estimates

Ensysce Biosciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ensysce Biosciences Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
15th of November 2024
Ensysce Biosciences Third Quarter 2024 Earnings Beats Expectations - Yahoo Finance
at news.google.com 
news
12th of November 2024
Ensysce Biosciences Reports Third Quarter 2024 Financial Results
at accesswire.com 
benzinga news
23rd of October 2024
Dow Tumbles Over 250 Points Boeing Posts Q3 Loss
at benzinga.com 
news
8th of October 2024
Ensysce Biosciences Announces Leadership Teams Participation in the Annual Pain Therapeuti...
at accesswire.com 
Yahoo News
24th of September 2024
Ensysce Biosciences Presenting at Upcoming Meetings
at finance.yahoo.com 
Yahoo News
13th of September 2024
Ensysce Biosciences Posts Video Updates from the IASP World Congress on Pain 2024
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ensysce Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ensysce Biosciences' short interest history, or implied volatility extrapolated from Ensysce Biosciences options trading.
When determining whether Ensysce Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ensysce Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ensysce Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ensysce Biosciences Stock:
Check out Ensysce Biosciences Backtesting and Ensysce Biosciences Hype Analysis.
For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensysce Biosciences. If investors know Ensysce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensysce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.94)
Revenue Per Share
0.274
Quarterly Revenue Growth
(0.63)
Return On Assets
(1.32)
Return On Equity
(4.28)
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensysce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.